Stockscreener 앱 받기
6.78
6.61%
-0.48
시간 외 거래:
6.55
-0.23
-3.39%
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: RxSight beats Q1 2026 forecasts, stock dips - Investing.com
RxSight (NASDAQ:RXST) Q1 2026 Results: Revenue Beats but Loss Widens Amid Cautious Market Reaction - ChartMill
RxSight, Inc. (RXST) Tops Q1 EPS by 12c - StreetInsider
RxSight (RXST) Q1 2026 revenue drops 18.5% as net loss nearly doubles - Stock Titan
Eye-lens maker RxSight says sales slowed, but kept 2026 target - Stock Titan
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook - Yahoo Finance UK
RxSight (NASDAQ: RXST) posts wider Q1 loss but keeps 2026 sales outlook - Stock Titan
Rxsight Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Behavioral Patterns of RXST and Institutional Flows - Stock Traders Daily
How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets - Yahoo! Finance Canada
RxSight, Inc. to Present at the Bank of America Healthcare Conference - Bluefield Daily Telegraph
Needham Maintains RxSight (RXST) Buy Recommendation - MSN
RxSight (RXST) to Release Earnings on Wednesday - MarketBeat
RxSight (NASDAQ: RXST) sets 2026 virtual meeting on directors, pay and auditor - Stock Titan
[ARS] RxSight, Inc. SEC Filing - Stock Titan
(RXST) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 - The Manila Times
RXST SEC FilingsRxsight, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RxSight (RXST) COO exercises stock options, now holding over 79,000 shares - Stock Titan
How The RxSight (RXST) Story Is Shifting With New Guidance And Street Price Targets - Yahoo Finance
RxSight (RXST) Stock: Mid-Year Review (Extends Gains) 2026-04-18Volatility Analysis - Cổng thông tin điện tử tỉnh Lào Cai
RxSight, Inc. (RXST) Stock Analysis: Exploring a 34% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Analysts’ Top Healthcare Picks: RxSight (RXST), Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
Needham Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $13 - Moomoo
RXST: Premium lens adoption grows as utilization deepens and international expansion accelerates - TradingView
RxSight (RXST) Stock: Valuation Analysis (Steady Decline) 2026-04-15Scalping - Cổng thông tin điện tử tỉnh Lào Cai
Volume Summary: Will RxSight Inc benefit from geopolitical trends2026 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
Trend Report: Is RxSight Inc forming a double bottom2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn
Retail Surge: Can RxSight Inc deliver consistent EPS growthWeekly Trend Summary & Fast Exit Strategy with Risk Control - baoquankhu1.vn
How (RXST) Movements Inform Risk Allocation Models - Stock Traders Daily
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Gains Report: What is RxSight Incs valuation compared to sector2026 Intraday Action & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Market Moves: Will RxSight Inc stock hit new highs in YEARQuarterly Earnings Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Analysis Recap: Will RxSight Inc benefit from geopolitical trendsJobs Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Investment Recap: Will RxSight Inc benefit from geopolitical trendsSwing Trade & Stepwise Trade Signal Guides - baoquankhu1.vn
RxSight Inc stock: 300,000 Lens Milestone Signals Growth Potential - AD HOC NEWS
RxSight Reaches 300,000 Light Adjustable Lens Implant Milestone - National Today
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 - Sahm
RxSight, Inc. (RXST) stock price, news, quote and history - Yahoo Finance Australia
RxSight reports 300,000 Light Adjustable Lens implants milestone By Investing.com - Investing.com South Africa
RxSight reports 300,000 Light Adjustable Lens implants milestone - Investing.com
RxSight reaches 300,000 Light Adjustable Lens implants since launch - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
RxSight (NASDAQ:RXST) Trading Down 3.7%Time to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
How The Story Is Shifting For RxSight (RXST) On Guidance Leadership And Valuation - Yahoo Finance
RXST PE Ratio & Valuation, Is RXST Overvalued - Intellectia AI
RxSight, Inc. (RXST) Stock Price, News, Quote & History - Yahoo! Finance Canada
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight to Participate in Annual Healthcare Conference - National Today
0.22%
0.70%
자본화:
|
볼륨(24시간):